Login / Signup

Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action.

Martin HoeniglRosanne SpruteAmir ArastehfarJohn R PerfectCornelia Lass-FlörlRomuald BellmannJuergen PrattesGeorge R ThompsonNathan P WiederholdMohanad M Al ObaidiBirgit WillingerMaiken Cavling ArendrupPhilipp KöhlerMatteo OliverioMatthias EggerIlan S SchwartzOliver Andreas CornelyPeter G PappasRobert Krause
Published in: Expert opinion on investigational drugs (2022)
spp.
Keyphrases
  • candida albicans
  • randomized controlled trial
  • phase ii
  • open label
  • phase iii